ABSTRACT Transluminal balloon valvuloplasty was used to treat congenital pulmonary valve stenosis in 20 patients. Follow-up cardiac catheterization was performed in 11 patients at intervals of from 2 to 12 months after the procedure. Peak One patient with pulmonary atresia and a hypoplastic right ventricle underwent a Brock procedure during the neonatal period. At 1 year of age she had evidence of persistent right ventricular outflow tract obstruction. Technique of valvuloplasty. The method of valvuloplasty was the same for each patient, regardless of age. Both groins were prepared and draped. A No. 7F sheath was introduced percutaneously into the right femoral vein. A No. 5F sheath was introduced into the left femoral vein, and a Teflon arterial cannula was introduced into the left femoral artery. Heparin (100 units/kg) was administered intravenously. Cardiac output was measured by the thermal dilution technique. Femoral arterial, right ventricular, and pulmonary arterial pressures were recorded.
TRANSLUMINAL BALLOON ANGIOPLASTY has been successfully used in the treatment of patients with stenoses of the coronary and peripheral circulations since 1976. 11 Recently transluminal angioplasty has been applied in pediatric cardiology to treat pulmonary valve stenosis,56 peripheral pulmonary artery stenosis, coarctation of the aorta,8 9 and coarctation restenosis.9, 10 Our experience with transluminal balloon angioplasty in 20 patients with pulmonary stenoses and the follow-up in 1 1 of these patients are included in this report.
Methods
Clinical material. Twenty patients with congenital pulmonary valve stenoses underwent transluminal balloon valvuloplasty at the Johns Hopkins Hospital between May 1981 and September 1983. The patients ranged in age from 3 months to 56 years. All 20 patients were referred to the Cardiovascular Diagnostic Laboratory for evaluation because of clinical evidence of significant pulmonary stenosis. Eleven of the patients underwent diagnostic cardiac catheterization at Johns Hopkins Hospital (seven patients) or at another institution (four patients) before being scheduled for balloon valvuloplasty. Nine patients underwent diagnostic catheterization and balloon valvuloplasty during the same procedure. Balloon valvuloplasty was presented to the patients and their parents as an investigational procedure approved by the Joint Committee for Clinical Investigation. Informed consent was obtained in writing for each patient before the procedure.
One patient with pulmonary atresia and a hypoplastic right ventricle underwent a Brock procedure during the neonatal period. At 1 year of age she had evidence of persistent right ventricular outflow tract obstruction.
Technique of valvuloplasty. greater than the dimension of the valve anulus was selected. Modification of the balloons, based on the experience with the first 10 patients, permitted rapid inflation and deflation to minimize the time of occlusion of the right ventricular outflow tract. " l Modifications included shortening balloon length from 4 to 3 cm and increasing the cross-sectional area of the balloon inflation lumen. The balloon used for dilation was attached through a pressure gauge to a 20 ml syringe that was filled with diluted (30%) contrast material. All air was evacuated from the balloon and as a test it was filled and emptied several times. It was then wrapped around the catheter in a clockwise direction. The balloon-forming tool, which is packaged with the balloon, was temporarily placed on the balloon to maximize wrapping around the catheter for easier percutaneous insertion.
The catheter used for dilatation was advanced over the 0.035 inch guidewire and introduced into the right femoral vein with a counterclockwise rotation as the balloon entered the vein. The guidewire was held taut to avoid looping in the heart and the catheter was advanced into the right ventricular outflow tract with the stenotic valve at the center of the balloon. The guidewire was left in position in the left pulmonary artery to stabilize the tip of the stiff catheter during the balloon inflation. This made it possible to adjust the position of the balloon rapidly and to minimize the possibility of damage to the pulmonary artery.
A No. SF catheter was passed into the right ventricle from the left femoral vein to monitor right ventricular pressure during balloon inflation. The electrocardiogram, femoral arterial pressure, and right ventricular pressure were recorded continuously during dilatation. The balloon was inflated by hand pressure. The "waisting" (visible indentation of the balloon caused by the stenotic valve) of the balloon was observed by fluoroscopy and the inflation pressure required to eliminate the indentation of the balloon was noted by an assistant. Disappearance of the waist occurred suddenly as the valve was opened. Peak inflation pressure usually ranged from 45 to 60 psi. The balloon was rapidly deflated and then reinflated twice subsequently to document that there was no waisting of the balloon at the early phase of inflation. Figure  1 shows the inflated balloon during valvuloplasty in one of the patients. Oxygen (by mask) and intravenous atropine (0.01 mg/ kg) were administered if bradycardia was observed during the first balloon inflation (three patients).
The dilatation balloon catheter was withdrawn and removed from the vein with a counterclockwise rotation while suction was applied to the balloon to maximally deflate it. Hemostasis was achieved by direct compression of the right groin. A thermal dilution catheter was advanced to the pulmonary artery from the left femoral vein and cardiac output was again measured, as were the pulmonary arterial, right ventricular, and femoral arterial pressures. The venous catheter and arterial cannula were removed from the left groin and hemostasis was achieved by direct compression. The heparinization was not reversed at the end of the procedure and no long-term anticoagulation therapy was instituted.
The ages of the patients and balloon sizes are shown in chronologic order according to timing of the procedure in table 1. There were no complications in performing valvuloplasty in any of these patients. To compare patients of various ages and with different systemic arterial pressures, the right ventricular pressure was expressed as a percentage of systemic pressure (right ventricular pressure/femoral arterial pressure x 100). The values for the 18 patients with typical pulmonary valve stenoses are shown in figure  2 . Mean right ventricular pressure/femoral arterial pressure (%) decreased from 80 ± 26% to 38 ± 7% (p < .001) after the valvuloplasty.
In three patients right ventriculography was performed immediately after valvuloplasty. Their dexes were not significantly different from the results immediately after valvuloplasty. By clinical evaluation each of the 18 patients with typical pulmonary valve stenosis had a decrease in the intensity of the systolic murmur with a change in quality of the murmur to a lower frequency with early systolic peaking. None of the patients developed an early diastolic murmur either immediately after valvuloplasty or at serial follow-up examinations. This suggests that no significant pulmonary valve insufficiency was created by the balloon valvuloplasty.
Dysplastic pulmonary valve. 
